Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Patient-based prediction algorithm of relapse after allo-HSCT for acute Leukemia and its usefulness in the decision-making process using a machine learning approach.
Fuse K, Uemura S, Tamura S, Suwabe T, Katagiri T, Tanaka T, Ushiki T, Shibasaki Y, Sato N, Yano T, Kuroha T, Hashimoto S, Furukawa T, Narita M, Sone H, Masuko M. Fuse K, et al. Among authors: kuroha t. Cancer Med. 2019 Sep;8(11):5058-5067. doi: 10.1002/cam4.2401. Epub 2019 Jul 15. Cancer Med. 2019. PMID: 31305031 Free PMC article.
The association of level of reduction of Wilms' tumor gene 1 mRNA transcript in bone marrow and outcome in acute myeloid leukemia patients.
Shibasaki Y, Seki Y, Tanaka T, Miyakoshi S, Fuse K, Kozakai T, Kobayashi H, Ushiki T, Abe T, Yano T, Moriyama M, Kuroha T, Isahai N, Takizawa J, Narita M, Koyama S, Furukawa T, Sone H, Masuko M. Shibasaki Y, et al. Among authors: kuroha t. Leuk Res. 2015 Jun;39(6):667-71. doi: 10.1016/j.leukres.2015.03.021. Epub 2015 Apr 7. Leuk Res. 2015. PMID: 25890432 Clinical Trial.
High-dose cytosine arabinoside and etoposide with total body irradiation as a preparatory regimen for allogeneic hematopoietic stem-cell transplantation in patients with acute lymphoblastic leukemia.
Sato N, Furukawa T, Kuroha T, Hashimoto S, Masuko M, Takahashi H, Yano T, Abe T, Fuse I, Koike T, Kishi K, Aizawa Y. Sato N, et al. Among authors: kuroha t. Bone Marrow Transplant. 2004 Aug;34(4):299-303. doi: 10.1038/sj.bmt.1704575. Bone Marrow Transplant. 2004. PMID: 15195078
Pharmacokinetic and pharmacodynamic analysis of cyclosporine A (CsA) to find the best single time point for the monitoring and adjusting of CsA dose using twice-daily 3-h intravenous infusions in allogeneic hematopoietic stem cell transplantation.
Furukawa T, Kurasaki-Ida T, Masuko M, Tsukada N, Okazuka K, Sato N, Yano T, Abe T, Momoi A, Shibasaki Y, Higashimura M, Karimata K, Moriyama M, Kuroha T, Takizawa J, Toba K, Narita M, Fuse I, Takahashi M, Aizawa Y. Furukawa T, et al. Among authors: kuroha t. Int J Hematol. 2010 Jul;92(1):144-51. doi: 10.1007/s12185-010-0610-0. Epub 2010 Jun 9. Int J Hematol. 2010. PMID: 20533008 Clinical Trial.
Plasmacytoid dendritic cell leukemia with potent antigen-presenting ability.
Narita M, Kuroha T, Watanabe N, Hashimoto S, Tsuchiyama J, Tochiki N, Saitoh A, Satoh N, Furukawa T, Toba K, Fuse I, Aizawa Y, Takahashi M. Narita M, et al. Among authors: kuroha t. Acta Haematol. 2008;120(2):91-9. doi: 10.1159/000165510. Epub 2008 Oct 24. Acta Haematol. 2008. PMID: 18948686
66 results